These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2178 related articles for article (PubMed ID: 27189134)
1. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134 [TBL] [Abstract][Full Text] [Related]
2. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178 [TBL] [Abstract][Full Text] [Related]
3. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets. Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676 [TBL] [Abstract][Full Text] [Related]
5. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS. Oladeji S; Mohylyuk V; Jones DS; Andrews GP Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354 [TBL] [Abstract][Full Text] [Related]
6. Fabrication of drug-loaded hydrogels with stereolithographic 3D printing. Martinez PR; Goyanes A; Basit AW; Gaisford S Int J Pharm; 2017 Oct; 532(1):313-317. PubMed ID: 28888978 [TBL] [Abstract][Full Text] [Related]
7. Effect of geometry on drug release from 3D printed tablets. Goyanes A; Robles Martinez P; Buanz A; Basit AW; Gaisford S Int J Pharm; 2015 Oct; 494(2):657-663. PubMed ID: 25934428 [TBL] [Abstract][Full Text] [Related]
8. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets. Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000 [TBL] [Abstract][Full Text] [Related]
9. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems. Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ Pharm Res; 2018 Nov; 36(1):4. PubMed ID: 30406349 [TBL] [Abstract][Full Text] [Related]
10. Formulation and Characterization of a 3D-Printed Cryptotanshinone-Loaded Niosomal Hydrogel for Topical Therapy of Acne. Wang Z; Liu L; Xiang S; Jiang C; Wu W; Ruan S; Du Q; Chen T; Xue Y; Chen H; Weng L; Zhu H; Shen Q; Liu Q AAPS PharmSciTech; 2020 May; 21(5):159. PubMed ID: 32476076 [TBL] [Abstract][Full Text] [Related]
11. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Verstraete G; Samaro A; Grymonpré W; Vanhoorne V; Van Snick B; Boone MN; Hellemans T; Van Hoorebeke L; Remon JP; Vervaet C Int J Pharm; 2018 Jan; 536(1):318-325. PubMed ID: 29217471 [TBL] [Abstract][Full Text] [Related]
12. Fused-filament 3D printing (3DP) for fabrication of tablets. Goyanes A; Buanz AB; Basit AW; Gaisford S Int J Pharm; 2014 Dec; 476(1-2):88-92. PubMed ID: 25275937 [TBL] [Abstract][Full Text] [Related]
13. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Wang J; Goyanes A; Gaisford S; Basit AW Int J Pharm; 2016 Apr; 503(1-2):207-12. PubMed ID: 26976500 [TBL] [Abstract][Full Text] [Related]
14. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing. Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898 [TBL] [Abstract][Full Text] [Related]
15. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery. Tan DK; Maniruzzaman M; Nokhodchi A Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002 [TBL] [Abstract][Full Text] [Related]
16. Fused-filament 3D printing of drug products: Microstructure analysis and drug release characteristics of PVA-based caplets. Goyanes A; Kobayashi M; Martínez-Pacheco R; Gaisford S; Basit AW Int J Pharm; 2016 Nov; 514(1):290-295. PubMed ID: 27863674 [TBL] [Abstract][Full Text] [Related]
17. Can filaments, pellets and powder be used as feedstock to produce highly drug-loaded ethylene-vinyl acetate 3D printed tablets using extrusion-based additive manufacturing? Samaro A; Shaqour B; Goudarzi NM; Ghijs M; Cardon L; Boone MN; Verleije B; Beyers K; Vanhoorne V; Cos P; Vervaet C Int J Pharm; 2021 Sep; 607():120922. PubMed ID: 34303815 [TBL] [Abstract][Full Text] [Related]
18. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. Genina N; Holländer J; Jukarainen H; Mäkilä E; Salonen J; Sandler N Eur J Pharm Sci; 2016 Jul; 90():53-63. PubMed ID: 26545484 [TBL] [Abstract][Full Text] [Related]
19. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. Zhang J; Feng X; Patil H; Tiwari RV; Repka MA Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768 [TBL] [Abstract][Full Text] [Related]
20. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets. Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]